261 filings
8-K
SAGE
Sage Therapeutics Inc
11 Jun 24
Departure of Directors or Certain Officers
4:16pm
8-K
SAGE
Sage Therapeutics Inc
11 Jun 24
Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
6:45am
10-Q
2024 Q1
SAGE
Sage Therapeutics Inc
Quarterly report
25 Apr 24
7:15am
8-K
SAGE
Sage Therapeutics Inc
25 Apr 24
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
6:46am
ARS
2023 FY
SAGE
Sage Therapeutics Inc
24 Apr 24
Annual report to shareholders
4:13pm
DEFA14A
jppo2jhp
24 Apr 24
Additional proxy soliciting materials
4:10pm
8-K
3i9evgnet7ptm6t3 gr5
19 Apr 24
Departure of Directors or Certain Officers
8:31am
8-K
fnqo5bafhabjdx6xc7
17 Apr 24
Regulation FD Disclosure
6:35am
SC TO-I/A
kcz01 8tdve2i0na
27 Mar 24
Issuer tender offer statement (amended)
4:09pm
8-K
4q6y8ieuyz
26 Mar 24
Departure of Directors or Certain Officers
8:34am
SC TO-I/A
j8mjbckbak 9p
21 Feb 24
Issuer tender offer statement (amended)
4:35pm
SC TO-I/A
31nxszry0cf
14 Feb 24
Issuer tender offer statement (amended)
4:09pm
S-8
8wo6x44h1us23
14 Feb 24
Registration of securities for employees
7:49am
8-K
c6np v51vtu44src79
14 Feb 24
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
SC TO-I/A
6lmyv 7jxayo6tt5
31 Jan 24
Issuer tender offer statement (amended)
5:25pm
8-K
mdl6ugq2zutxyv
31 Jan 24
Submission of Matters to a Vote of Security Holders
4:50pm
8-K
qgeovj 1fqbzc1
24 Jan 24
Entry into a Material Definitive Agreement
4:10pm
SC TO-I
lqe5 8mq3g6
23 Jan 24
Issuer tender offer statement
8:13am